MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Durata Therapeutics Company Profile (NASDAQ:DRTX)

Consensus Ratings for Durata Therapeutics (NASDAQ:DRTX) (?)
Ratings Breakdown: 4 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $24.00 (0.66% downside)

Current Analysts' Coverage Summary for Durata Therapeutics (NASDAQ:DRTX)
Show:
DateFirmActionRatingPrice TargetActions
10/15/2014Roth CapitalDowngradeBuy -> Neutral$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2014Credit SuisseDowngradeOutperform -> Neutral$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2014RBC CapitalDowngradeOutperform -> Sector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupLower Price Target$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2014GabelliInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014MLV & Co.Initiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2014Summer StreetInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2014Craig HallumInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2013WedbushDowngradeOutperform -> Neutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Janney Montgomery ScottInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha